Cite
Optimal Background Pharmacological Therapy for Heart Failure Patients in Clinical Trials: JACC Review Topic of the Week.
MLA
Fiuzat, Mona, et al. “Optimal Background Pharmacological Therapy for Heart Failure Patients in Clinical Trials: JACC Review Topic of the Week.” Journal of the American College of Cardiology (JACC), vol. 79, no. 5, Feb. 2022, pp. 504–10. EBSCOhost, https://doi.org/10.1016/j.jacc.2021.11.033.
APA
Fiuzat, M., Hamo, C. E., Butler, J., Abraham, W. T., DeFilippis, E. M., Fonarow, G. C., Lindenfeld, J., Mentz, R. J., Psotka, M. A., Solomon, S. D., Teerlink, J. R., Vaduganathan, M., Vardeny, O., McMurray, J. J. V., & O’Connor, C. M. (2022). Optimal Background Pharmacological Therapy for Heart Failure Patients in Clinical Trials: JACC Review Topic of the Week. Journal of the American College of Cardiology (JACC), 79(5), 504–510. https://doi.org/10.1016/j.jacc.2021.11.033
Chicago
Fiuzat, Mona, Carine E. Hamo, Javed Butler, William T. Abraham, Ersilia M. DeFilippis, Gregg C. Fonarow, Joann Lindenfeld, et al. 2022. “Optimal Background Pharmacological Therapy for Heart Failure Patients in Clinical Trials: JACC Review Topic of the Week.” Journal of the American College of Cardiology (JACC) 79 (5): 504–10. doi:10.1016/j.jacc.2021.11.033.